In vivo detection by 31P NMR of pentose phosphate pathway block secondary to biochemical modulation

NMR in Biomedicine

Volumn 9, Issue 3, 1996, Pages 114-120

  Mahmood, U ^a   Street, J C ^a   Matei, C ^a   Ballon, D ^a   Martin, D S ^a   Koutcher, J A ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Catholic Medical Centre   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MURINAE;

6 AMINONICOTINAMIDE; 6 METHYLTHIOINOSINE; ANTINEOPLASTIC AGENT; ASPARTIC ACID; DRUG DERIVATIVE; PHOSPHONOACETIC ACID; PHOSPHORUS; SPARFOSIC ACID; TERATOGENIC AGENT;

ANIMAL; ARTICLE; C3H MOUSE; CELL DIVISION; COMPARATIVE STUDY; DRUG EFFECT; EXPERIMENTAL NEOPLASM; MALE; METABOLISM; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PENTOSE PHOSPHATE CYCLE;

6-AMINONICOTINAMIDE; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARTIC ACID; CELL DIVISION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLTHIOINOSINE; MICE; MICE, INBRED C3H; PENTOSE PHOSPHATE PATHWAY; PHOSPHONOACETIC ACID; PHOSPHORUS; TERATOGENS;

EID: 0029658469     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199605)9:3<114::AID-NBM413>3.0.CO;2-O     Document Type: Review

References (42)

1. Koutcher, J. A., Alfieri, A. A., Stolfi, R. L., Devitt, M. L., Colofiore, J. R., Nord, L. D. and Martin, D. S. Potentiation of a 3 drug chemotherapy regimen by radiation. Cancer Res. 53, 3518-3523 (1993).
2. Stolfi, R. L., Colifiore, J. R., Nord, L. D., Koutcher, J. A. and Martin, D. S. Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast tumors with a 5-FU containing drug regimen. Cancer Res. 52, 4074-4081 (1992).
3. Martin, D. S., Stolfi, R. L., Colofiore, J. R., Nord, L. D. and Sternberg, S. Biochemical modulation of tumor cell energy in vivo: II. A lower dose of adriamycin is required and a greater antitumor activity is induced when cellular energy is depressed. Cancer Invest. 12, 296-307 (1994).
4. Martin, D. S., Stolfi, R. L., Sawyer, R. C., Spiegelman, S., Casper, E. S. and Young, C. W. Therapeutic utility of utilizing low doses of N-(phosphonacetyl)-L-aspartic acid in combination with 5-fluorouracil: a murine study with clinical relevance. Cancer Res. 43, 2317-2321 (1983).
5. Warnick, C. T. and Paterson, A. R. P. Effect of methylthioninosine on nucleotide concentrations in L5178Y Cells. Cancer Res. 33, 1711-1715 (1973).
6. Johnson, W. J. and McColl, J. D. 6-aminonicotinamide, a potent nicotinamide antagonist. Science 122, 834 (1955).
7. Martin, D. S., Dietrich, L. S. and Shils, M. E. Quantiative biochemical differences between tumor and host as a basis for cancer chemotherapy. V. Niacin and 6-aminonicotinamide. Cancer Res. 17, 600-604 (1957).
8. Hunting, D., Gowans, B. and Henderson, J. F. Effects of 6-aminonicotinamide on cell growth. Poly (ADP-ribose) synthesis and nucleotide metabolism. Biochem. Pharmacol. 34, 3999-4003 (1985).
9. Herken, H., Lange, K., and Kolbe, H. Brain disorders induced by pharmacological blockade of the pentose phosphate pathway. Biochem. Biophys. Res. Comm. 36, 93-100 (1969).
10. O'Dwyer, P. J., Paul, A. R., Walczak, J. et al. Phase II study of biochemical modulation of FU by low dose PALA in patients with colorectal cancer. J. Clin. Oncol. 8, 1497-1503 (1990).
11. Herter, F. P., Weissman, S. G., Thompson, H. G., Hyman, G. and Martin, D. S. Clinical experience with 6-aminonicotinamide. Cancer Res. 21, 31-37 (1961).
12. O'Dwyer, P. J., Hudes, G. R., Colofiore, J., Walczak, J., Huffman, J., LaCreta, F. P., Comis, R. L., Martin, D. S. and Ozols, R. Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylcaptopurine riboside: optimization of 6-methylmercaptopurine riboside dose and schedule through biochemical analysis of sequential tumor biopsy specimens. J. Natl. Cancer Inst. 83, 1235-1240 (1991).
13. Varnes, M. Inhibition of pentose cycle of A549 cells by 6AN: consequences for aerobic and hypoxic radiation response and for radiosensitizer action. Natl. Cancer. Inst. Monogr. 6, 199-203 (1988).
14. Berger, N. A., Catino, D. M. and Vietta, T. J. Synergistic antileukemic effect of 6AN and 1,3 bis(2-chloroethyl)-1-nitrosourea on L1210 cells in vitro and in vivo. Cancer Res. 42, 4382-4386 (1982).
15. Martin, D. S., Kligerman, M. M. and Fugman, R. A. Radiotherapy and adjuvant combination chemotherapy (6-aminonicotinamide and 6-mercaptopurine). Cancer Res. 18, 893-896 (1958).
16. 31P NMR investigation of effect of 6-aminonicotinamide on metabolism of RIF-1 tumour cells in vitro. J. Biol. Chem. 271, 4113-4119 (1996).
17. 31P MR spectroscopic study. Biochem. Biophys. Res. Comm. 164, 947-953 (1989).
18. Stone, H. B. and Sinesi, M. S. Testing of new hypoxic cell sensitizers in vivo. Radiat. Res. 91, 186-198 (1982).
19. Ballon, D., Mahmood, U., Jakubowski, A. and Koutcher, J. A. Resolution enhanced NMR spectroscopy in biological systems via magnetic susceptibility matched sample immersion chambers. Magn. Reson. Med. 30, 754-758 (1993).
20. Koutcher, J. A., Alfieri, A. A., Devitt, M. L., Rhee, J. G., Kornblith, A. B., Mahmood, U., Merchant, T. E. and Cowburn, D. Quantitative changes in tumor metabolism, partial pressure of oxygen, and radiobiological oxygenation status post radiation. Cancer Res. 52, 4620-4627 (1992).
21. 31P NMR spectroscopy. Cancer Res. 54, 4885-4891 (1994).
22. 31P NMR spectroscopy. NMR Biomed. 8, 149-158 (1995).
23. 31P NMR changes with growth in radioresistant and radiosensitive tumors, Radiat. Res. 121, 312-319 (1990).
24. Moyer, J. D. and Handschumacher, R. E. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(Phosphonacetyl)-L-aspartate. Cancer Res. 39, 3089-3094 (1979).
25. 1H NMR investigation in vitro of normal and abnormal human liver. Biochim. Biophys. Acta. 1225, 71-77 (1993).
26. 31P NMR study of the responses of a mammary carcinoma to chemotherapy. Proc. 3rd Scientific Meeting of the Society of Magnetic Resonance. Nice, France, p. 1687 (1995).
27. 31P resonances of pohsphoethanolamine and phosphocreatine. NMR Biomed. 5, 364-367 (1992).
28. 31P NMR detection of pentose phosphate pathway block and enhancement of radiation sensitivity with 6-aminonicotinamide. Magn. Reson. Med. (in press).
29. 31P NMR spectral changes induced by biochemical modulation. Cancer Invest, (in press).
30. Ofori-Nkansah, N. and von Bruchhausen, F. Metabolic alterations in Yoshida ascites tumor cells caused by 6AN and prevented by nicotinamide. Naunyn-Schmiedeberg's Arch. Pharmacol. 272, 156-168 (1972).
31. Epel, D. Effects of carbon monoxide on ATP level and the rate of mitosis in the sea urchin egg. J. Cell Biol. 17, 315-319 (1963).
32. Mazia, D. Synthetic activities leading to mitosis. J. Cell. Comp. Physiol. 62, 123-140 (1963).
33. Zotin, A. I., Milman, L. S. and Faustov, V. S. ATP level and cleavage of sea urchin eggs Strongylocentrotus drobachiensis (O. F. Muller). Exptl. Cell Res. 39, 567-576 (1965).
34. Sweet, S. and Singh, G. Accumulation of human promyelocytic leukemic (HL-60) cells at two energetic cell cycle checkpoints. Cancer Res. 55, 5164-5167 (1995).
35. Jain, V. K., Porschen, W. and Feinendegen, L. E. Optimization of cancer therapy: part II-effects of combining 2-deoxy-D-glucose treatment with gamma-irradiation on sarcoma-180. Ind. J. Expl. Biol. 15, 714-718 (1977).
36. Jain, V. K., Kalia, V. K., Sharma, R., Maharajan, V. and Menon, M. Effects of 2-deoxy-D-glucose on glycolysis, proliferation kinetics and radiation response of human cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 11, 943-950 (1985).
37. Dwarkanath, B. S. and Jain, V. K. Energy linked modifications of the radiation response in a human cerebral glioma cell line. Int. J. Radiat. Oncol. Biol. Phys. 17, 1033-1040 (1989).
38. Ling, C., Robinson, E. and Shrieve, D. Repair of radiation induced damage dependence on oxygen and energy status. Int. J. Radiat. Oncol. Biol. Phys. 15, 1179-1186 (1988).
39. Waldstein, E. A., Sharon, R. and Ben-Ishai, R. Role of ATP in excision repair of ultraviolet radiation damage in E. coli. Proc. Natl. Acad. Sci. 71, 2651 (1974).
40. Dressler, S. L. and Lieberman, M. W. Requirement of ATP for specific incision of UV damaged DNA during excision repair in permeable human fibroblasts. J. Biol. Chem. 258, 12269-12273 (1983).
41. Matsudaria, H., Furino, I. and Otsuka, H. Possible requirements of ATP for the rejoining of X-ray induced breaks in the DNA of Ehrlich ascites tumor cells. Int. J. Radiat. Biol. 17, 339-347 (1970).
42. Purohit, S. C. and Pohlit, W. Experimental evaluation of the glucose anti-metabolite, 2-deoxy-o-glucose (2DG) as a possible adjuvant to radiotherapy of tumors: I. Kinetics of growth and survival of Ehrlich ascites tumor cells (EATC) in vitro and of growth of solid tumors after 2-DG and X-irradiation. Int. J. Radiat. Oncol. Biol. Phys. 8, 495-499 (1982).